Status:
COMPLETED
BCI-controlled NMES in Subacute Stroke
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
Ecole Polytechnique Fédérale de Lausanne
Clinique Romande de Readaptation
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke patients with severe upper limb movement deficits have limited treatment options and often remain severely handicapped at the chronic stage. Recent findings have suggested that poor motor reco...
Eligibility Criteria
Inclusion
- Ischemic or hemorrhagic stroke
- Stroke onset ≤ 8 weeks
- Severe, unilateral motor upper extremity hemiparesis (≤15 Fugl-Meyer Score)
- Ability to give informed consent
Exclusion
- Second stroke during rehabilitation
- Skull breach
- Cardiac pacemaker
- Metallic implants in the brain
- Delirium or disturbed vigilance
- Inability to follow treatments sessions
- Severe language comprehension deficits
- Severe dystonia or spasticity
- Severe co-morbidity (ex, traumatic, rheumatologic, neurodegenerative diseases)
- Pregnancy
Key Trial Info
Start Date :
January 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03379532
Start Date
January 26 2018
End Date
April 30 2024
Last Update
May 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Austin
Austin, Texas, United States, 78712
2
Division of Neurorehabilitation, University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland, 1211